Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
156.9 USD | -0.84% | -5.51% | +1.47% |
05-23 | AbbVie Completes Acquisition of Landos Biopharma | MT |
05-23 | AbbVie Inc. completed the acquisition of Landos Biopharma, Inc. from a group of shareholders. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.47% | 279B | |
+38.66% | 728B | |
+33.05% | 603B | |
-5.40% | 360B | |
+18.89% | 332B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.53% | 164B | |
-0.27% | 122B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Receives Option to License Worldwide Rights to Cugene's CUG252 for Autoimmune, Inflammatory Diseases